Stocks and Investing
Stocks and Investing
Fri, January 3, 2020
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Thu, January 2, 2020
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Debjit Chattopadhyay Maintained (WVE) at Strong Buy with Decreased Target to $20 on, Jan 2nd, 2020
Published on 2024-10-26 19:33:01 - WOPRAI, Debjit Chattopadhyay
Debjit Chattopadhyay of HC Wainwright & Co., Maintained "Wave Life Sciences Ltd." (WVE) at Strong Buy with Decreased Target from $33 to $20 on, Jan 2nd, 2020.
Debjit has made no other calls on WVE in the last 4 months.
There is 1 other peer that has a rating on WVE. Out of the 1 peers that are also analyzing WVE, all agrees with Debjit's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Mani Foroohar of "SVB Leerink" Downgraded from Buy to Hold and Decreased Target to $10 on, Tuesday, December 31st, 2019
Contributing Sources